Cargando…
Exogenous Insulin Antibody Syndrome in Patients with Type 2 Diabetes
BACKGROUND: Exogenous insulin antibody syndrome (EIAS) is an immunological disorder caused by circulating insulin antibodies (IAs), featuring hypersensitivity to exogenous insulin and insulin resistance. With the wide use of recombinant human insulin and insulin analogs, there has been a significant...
Autores principales: | Han, Chen-Yu, Ye, Xiao-Mei, Lu, Jia-Ping, Jin, Hai-Ying, Xu, Wei-Wei, Wang, Ping, Zhang, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312206/ https://www.ncbi.nlm.nih.gov/pubmed/37398942 http://dx.doi.org/10.2147/DMSO.S410349 |
Ejemplares similares
-
Type 1 diabetes complicated with cyclic vomiting syndrome and exogenous insulin antibody syndrome: A case report
por: Geng, Leiluo, et al.
Publicado: (2022) -
Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients
por: Hu, Xiaolei, et al.
Publicado: (2017) -
Effect of Benaglutide on Gut Microbiota and Fecal Metabolites in Patients with Type 2 Diabetes Mellitus
por: Han, Chen-Yu, et al.
Publicado: (2023) -
Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma
por: Fang, Shen-Cun, et al.
Publicado: (2017) -
Exogenous insulin antibody syndrome treated with plasma exchange after an incomplete response to immunosuppressive therapy
por: Zhuang, Yuan, et al.
Publicado: (2021)